Goldie R G, Papadimitriou J M, Paterson J W, Rigby P J, Spina D
Br J Pharmacol. 1986 Jul;88(3):621-8. doi: 10.1111/j.1476-5381.1986.tb10243.x.
The binding of the beta-adrenoceptor radioligand [125I]-iodocyanopindolol (I-CYP) has been studied in pig lung parenchyma and the distribution of binding sites visualised by light microscopic autoradiography. I-CYP binding was saturable (maximum binding capacity Bmax = 51 +/- 3 fmol mg-1 protein), involving sites with high affinity (dissociation constant KD = 73 +/- 10 pM). Specific I-CYP binding was displaceable both by beta-adrenoceptor agonists ((-)-isoprenaline greater than (-)-adrenaline greater than (+/-)-fenoterol greater than (-)-noradrenaline greater than (+)-isoprenaline greater than (+/-)-RO363) and antagonists ((+/-)-propranolol greater than ICI-118551 greater than atenolol), indicating a predominance of beta 2-adrenoceptors. Further analysis showed that displacement data for the beta 1-selective antagonist atenolol and the beta 2-selective antagonist ICI-118551 were fitted best to a 2 binding site model and that both beta 1- and beta 2-adrenoceptors were present in pig lung in the ratio 28:72 respectively. Autoradiographic grains were localized over tissue and were most dense over alveolar walls greater than vascular endothelium greater than vascular smooth muscle greater than bronchial smooth muscle = bronchial epithelium. Atenolol (10(-5) M) caused a 31% reduction in specific grain density over alveolar wall tissue, while a 10 fold lower concentration of ICI-118551 (10(-6) M) caused a 50% decrease. These results are consistent with binding data in pig lung parenchyma demonstrating a mixed population of beta-adrenoceptors with a predominance of the beta 2 subtype. 6 It is possible that the previously described relaxant responses of the pig lung parenchyma strip to beta-agonists, mediated via beta 2-adrenoceptors, resulted from the sum of reactivities in airway and vascular smooth muscle together with relaxation of alveolar interstitial cells.
已对猪肺实质中β - 肾上腺素能受体放射性配体[¹²⁵I] - 碘氰吲哚洛尔(I - CYP)的结合进行了研究,并通过光学显微镜放射自显影观察结合位点的分布。I - CYP结合具有饱和性(最大结合容量Bmax = 51±3 fmol mg⁻¹蛋白质),涉及具有高亲和力的位点(解离常数KD = 73±10 pM)。特异性I - CYP结合可被β - 肾上腺素能受体激动剂(( - ) - 异丙肾上腺素>( - ) - 肾上腺素>(±) - 非诺特罗>( - ) - 去甲肾上腺素>( + ) - 异丙肾上腺素>(±) - RO363)和拮抗剂((±) - 普萘洛尔>ICI - 118551>阿替洛尔)所取代,表明主要为β₂ - 肾上腺素能受体。进一步分析表明,β₁选择性拮抗剂阿替洛尔和β₂选择性拮抗剂ICI - 118551的取代数据最符合双结合位点模型,且猪肺中β₁和β₂ - 肾上腺素能受体的比例分别为28:72。放射自显影颗粒定位于组织上,在肺泡壁上最为密集>血管内皮>血管平滑肌>支气管平滑肌 = 支气管上皮。阿替洛尔(10⁻⁵ M)使肺泡壁组织上的特异性颗粒密度降低31%,而浓度低10倍的ICI - 118551(10⁻⁶ M)则使颗粒密度降低50%。这些结果与猪肺实质中的结合数据一致,表明存在混合的β - 肾上腺素能受体群体,其中β₂亚型占主导。6先前描述的猪肺实质条带对β - 激动剂的舒张反应可能是通过β₂ - 肾上腺素能受体介导的,这是气道和血管平滑肌反应性总和以及肺泡间质细胞舒张的结果。